Genevieve Moyer, MD
Assistant Professor, Medicine-Hematology
Download CV
Medical School:
Department: Medicine-Hematology
Medical School:
- MD, Saint Louis University School of Medicine (2011)
- MS, University of Colorado Denver (2018)
- BS, Arizona State University (AZ) (2007)
- Saint Louis University School of Medicine Program, Internal Medicine (2015)
- Saint Louis University School of Medicine Program, Hematology and Oncology (2018)
Department: Medicine-Hematology
Professional Titles
- Assistant Professor
Recognition & Awards
- Who's Who in Medicine Higher Education, Academic Keys (2019)
- Clinical Fellowship Award in Hemophilia and Rare Bleeding Disorders, HTRS/Novo Nordisk (2018)
- Golden Key International Honor Society, Golden Key (2018)
Research Interests
At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research in the area of cancer-associated thrombosis. I chose to study the venous thromboembolism characteristics of individuals from our institution who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. I discovered that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result of this endeavor, I have developed a career interest aimed at developing tools to risk stratify complex patients regarding their risk for bleeding and clotting simultaneously.
As my career has progressed, I have also discovered a passion for the treatment of women with bleeding disorders which has led to a goal of balancing our knowledge and understanding of bleeding disorders across genders.
I continue to pursue the development of novel tools to aid in bleeding and clotting risk stratification while also spending time investigating these knowledge gaps regarding how to best care for women, transgender, and gender non-binary individuals with disorders of hemostasis.
Publications
- Warren BB, Moyer GC, Manco-Johnson MJ. Hemostasis in the Pregnant Woman, the Placenta, the Fetus, and the Newborn Infant. Semin Thromb Hemost. 2023 Feb 7. [Epub ahead of print] PubMed PMID: 36750218
- Hayden A, Candelario N, Moyer G. Recombinant porcine factor VIII in acquired hemophilia A: Experience from two patients and literature review. Res Pract Thromb Haemost. 2022 Feb;6(2):e12688. PubMed PMID: 35356668
- Huguelet PS, Laurin JL, Thornhill D, Moyer G. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2022 Apr;35(2):147-152.e1. PubMed PMID: 34775059
- Huguelet PS, Laurin JL, Thornhill D, Moyer G. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome. J Pediatr Adolesc Gynecol. 2021 Nov 11. [Epub ahead of print] PubMed PMID: 34775059
- Warren BB, Chan A, Manco-Johnson M, Branchford BR, Buckner TW, Moyer G, Gibson E, Thornhill D, Wang M, Ng CJ. Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single-center report. Res Pract Thromb Haemost. 2021 Jul;5(5):e12571. PubMed PMID: 34377887
- G. Moyer, B.B. Warren, L. Jacobson, C.H. Baird, D. Thornhill, J. Smith, C. Ng, T.W. Buckner, B. Branchford, M. Wang, M.J. Manco-Johnson. Emicizumab beyond Annualized Bleeding Rate: Do Laboratory Assays Help Predict Emicizumab Effects? 2020 Virtual XXVII Congress of the International Society on Thrombosis and Haemostasis. Abstract Presentation Number PB1164, ePoster
- Genevieve Moyer, Patricia Huguelet; Iron Deficient Anemia May Obscure a Diagnosis of Low VWF, VWD or Mild Hemophilia a in Biological Females with Heavy Menstrual Bleeding. Blood2020; 136 (Supplement 1): 32–33. doi: https://doi.org/10.1182/blood-2020-138697
- Genevieve Moyer, Patricia Huguelet; A Comparison of Scores from the ISTH-BAT and Self-BAT in Adolescent Biological Females with Heavy Menstrual Bleeding. Blood 2020; 136 (Supplement 1): 37–38. doi: https://doi.org/10.1182/blood-2020-138693
- 3. Hematology in the Adolescent Female. Hypermobility syndromes in Heavy Menstrual Bleeding. Lakshmi V. Srivaths. Springer Nature Switzerland Ag. 2020.
- Moyer GC, Bannow BS, Thornburg C, Rosovsky R, Wang TF, Woller S, Thornhill D, Kreuziger LB. Venous Thromboembolism: A Survey of Oral Anticoagulant Preferences in the Treatment of Challenging Patient Populations. Clin Appl Thromb Hemost. 2018 Oct 2;:1076029618804080. [Epub ahead of print] PubMed PMID: 30278776
Practice Locations
Hemophilia & Thrombosis Center
13199 E. Montview Blvd
Suite 100
Aurora, CO 80045
303-724-0724
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400
Hospital Affiliation
13199 E. Montview Blvd
Suite 100
Aurora, CO 80045
303-724-0724
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000
UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400
Hospital Affiliation
- University of Colorado Hospital
Specialty Information
Specialties
- Hematology and Oncology, Board Certification (2018, 2018)
- Internal Medicine, Board Certification (2014)
- Blood / Lymphatic System - Clotting Disorders
- Blood / Lymphatic System
- Blood / Lymphatic System - Bleeding Disorders
- Blood / Lymphatic System - Blood Disorders
Care Philosophy
I believe strongly in the importance of getting to know each patient as an individual and engaging them in shared decision making. To accomplish this, I strive to ensure that all my patients understand their diagnosis so that they feel empowered in the pursuit of their own health and wellness.
I believe strongly in the importance of getting to know each patient as an individual and engaging them in shared decision making. To accomplish this, I strive to ensure that all my patients understand their diagnosis so that they feel empowered in the pursuit of their own health and wellness.
Personal Interests
My medical specialty is classical hematology with an emphasis on hemostasis and thrombosis. I am committed to improving the management of women, transgender, and gender non-binary individuals with bleeding disorders. My primary research endeavors are focused on these populations with an overarching goal of developing novel risk stratification tools that can predict future bleeding and thrombotic events and help guide medical management.
Public Speaking
Yes
Women with bleeding disorders. Novel therapies in hemophilia.
My medical specialty is classical hematology with an emphasis on hemostasis and thrombosis. I am committed to improving the management of women, transgender, and gender non-binary individuals with bleeding disorders. My primary research endeavors are focused on these populations with an overarching goal of developing novel risk stratification tools that can predict future bleeding and thrombotic events and help guide medical management.
Public Speaking
Yes
Women with bleeding disorders. Novel therapies in hemophilia.
General Information
Medical Schools:
- MD, Saint Louis University School of Medicine (2011)
Graduate Schools:
- MS, University of Colorado Denver (2018)
Undergraduate Schools:
- BS, Arizona State University (AZ) (2007)
Residency Programs:
- Saint Louis University School of Medicine Program, Internal Medicine (2015)
Fellowships:
- Saint Louis University School of Medicine Program, Hematology and Oncology (2018)
Languages: English
Department: Medicine-Hematology